Mag-2 (Magnesium Pidolate)

Magnesium pidolate releases magnesium ions that serve as cofactors for many enzymatic processes, including ATP production, protein synthesis, and ion transport. By supplying these ions, it helps maintain normal nerve transmission, muscle contraction‑relaxation cycles, and overall cellular metabolism.

The appropriate dose of Mag-2 is determined by the prescribing healthcare professional based on the individual’s clinical condition, laboratory results, and other medications. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for magnesium pidolate during pregnancy and lactation are limited. Healthcare providers should evaluate the risk‑benefit ratio before prescribing Mag-2 to pregnant or nursing women, and it should only be used if clearly indicated.

To order Mag-2, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Mag-2 provides magnesium in the pidolate salt form, which is well‑absorbed and may be gentler on the gastrointestinal tract compared with some inorganic salts such as magnesium oxide. Clinical choice depends on factors like bioavailability, tolerability, cost and patient preference.

Mag-2 should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Mag-2 is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the prescriber’s guidance regarding timing to optimise absorption and minimise gastrointestinal discomfort.

Serious risks include hypermagnesemia, which can cause cardiac arrhythmias, severe hypotension, and respiratory depression, especially in patients with renal impairment. Allergic reactions such as rash, swelling or anaphylaxis, though rare, also require immediate medical attention.

Mag-2 should be avoided in individuals with severe renal failure, known hypersensitivity to magnesium pidolate, or those taking medications that may cause dangerous magnesium accumulation without appropriate monitoring. Consultation with a healthcare professional is essential before starting therapy.